Purdue Pharma L.P., the Supreme Court held that the Bankruptcy Code does not authorize a bankruptcy court to grant a release and injunction that extinguishes direct claims against nondebtor third ...

Purdue Pharma on Wednesday filed a new Chapter 11 reorganization plan with the U.S. Bankruptcy Court for the Southern ...

Purdue Pharma planned to exit bankruptcy last year under terms that gave the Sacklers a full release from all civil opioid claims even though they themselves were not declaring bankruptcy.

South Carolina Attorney General Alan Wilson announced Tuesday that the Palmetto State is expected to receive over $70 million ...

Previously at the epicenter of the U.S. opioid crisis, Purdue Pharma is looking to reenter ... While around 140,000 people have made legal claims over alleged harm from Purdue’s opioid products ...

The deal, agreed to by Purdue Pharma, the Sackler family members who ... They’ve continued to deny claims of any wrongdoing. Collectively, family members have been estimated to be worth billions ...

But the company was facing trillions in claims and resorted – along with ... represent the financial interests of victims in the Purdue Pharma bankruptcy case. For two years, he served on ...

Purdue Pharma’s owners from the Sackler family have struck a new $6.5 billion settlement of mass litigation alleging they fueled addiction, reopening a path to end the longest and costliest ...

Purdue Pharma on Wednesday filed a new bankruptcy reorganization plan to resolve mass lawsuits alleging that the OxyContin maker and its Sackler family owners contributed to the opioid crisis.

NEW YORK, Oct 31 (Reuters) - Purdue Pharma is close to a new bankruptcy ... s creditors has been allowed to sue the Sacklers over claims that the family drained over $11 billion from the company ...

NEW YORK, Sept 5 (Reuters) - Purdue Pharma on Thursday received an 18-day ... The Supreme Court ruled that bankruptcy courts cannot release legal claims against non-debtors, like the Sacklers ...